Your browser doesn't support javascript.
Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases.
Masanam, Hema Brindha; Perumal, Govindaraj; Krishnan, Saravanan; Singh, Sachin Kumar; Jha, Niraj Kumar; Chellappan, Dinesh Kumar; Dua, Kamal; Gupta, Piyush Kumar; Narasimhan, Ashwin Kumar.
  • Masanam HB; Advanced Nano-Theranostics (ANTs), Biomaterials Lab, Department of Biomedical Engineering, SRM Institute of Science & Technology, Kattankulathur, Tamil Nadu, 603 203, India.
  • Perumal G; Department of Conservative Dentistry & Endodontics, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Velappanchavadi, Chennai, 600 077, India.
  • Krishnan S; Department of Biomedical Engineering, Rajalakshmi Engineering College, Thandalam, Chennai, 602 105, India.
  • Singh SK; Creative Carbon Labs Pvt Ltd, Chennai, Tamil Nadu, 600113, India.
  • Jha NK; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
  • Chellappan DK; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Knowledge Park III, Greater Noida, Uttar Pradesh, 201310, India.
  • Dua K; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia.
  • Gupta PK; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia.
  • Narasimhan AK; Department of Life Sciences, School of Basic Sciences & Research (SBSR), Sharda University, Knowledge Park III, Greater Noida, Uttar Pradesh, 201310, India.
Nanomedicine (Lond) ; 17(25): 1981-2005, 2022 10.
Article in English | MEDLINE | ID: covidwho-2271158
ABSTRACT
The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable better spatial-temporal resolution and a high signal-to-noise ratio in imaging. Targeted nanoimaging agents have been used to bind specific tissues in inflammatory lungs for early-stage diagnosis. However, nanobased imaging approaches for inflammatory lung diseases are still in their infancy. This review provides a solution-focused approach to exploring medical imaging technologies and nanoprobes for the detection of inflammatory lung diseases. Prospects for the development of contrast agents for lung disease detection are also discussed.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nanoparticles / COVID-19 / Antineoplastic Agents Type of study: Diagnostic study Limits: Humans Language: English Journal: Nanomedicine (Lond) Year: 2022 Document Type: Article Affiliation country: Nnm-2021-0427

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nanoparticles / COVID-19 / Antineoplastic Agents Type of study: Diagnostic study Limits: Humans Language: English Journal: Nanomedicine (Lond) Year: 2022 Document Type: Article Affiliation country: Nnm-2021-0427